Bleeding | No bleeding | Univariate (p value) | Multivariate OR | 95 % CI | Multivariate (p value) | |
---|---|---|---|---|---|---|
Age | 72.2 ± 8.6 | 73.6 ± 8.5 | 0.40 | 0.26 | 0.01-9.30 | 0.45 |
Sex (M/F) | 29/4 | 170/42 | 0.71 | |||
Anticoagulants vs. Antiplatelet drugsa | 21:12 | 114:98 | 0.28 | 1.36 | 0.61-3.17 | 0.45 |
Number of antithrombotic drugs Multiple vs. singlea | 21:12 | 112:100 | 0.25 | 1.88 | 0.84-4.38 | 0.12 |
Type of heparin | 32:1 | 207:5 | 0.81 | |||
Unfractionated heparin vs. LMWH | ||||||
Dose adjustment of HBT | 17:16 | 36:176 | <0.001 | 5.06 | 2.29-11.3 | <0.001 |
Adjusted vs. Fixeda | ||||||
Timing of antithrombotic resumption Appropriate vs. Inappropriate | 16:17 | 119:93 | 0.51 |